| John L Andreshak, MD | |
|
240 Hospital Pl Ste 104, Soldotna, AK 99669-7559 | |
| (907) 714-5770 | |
| (907) 714-3111 |
| Full Name | John L Andreshak |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 240 Hospital Pl Ste 104, Soldotna, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740270792 | NPI | - | NPPES |
| P01141220 | Other | IL | MEDICARE RR |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Peninsula General Hospital Inc | 4587552575 | 85 |
News Archive
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Increasing numbers of children and adolescents are being given antipsychotic drugs in Germany, as Christian Bachmann and colleagues found out in a study published in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2014; 111(3): 25 - 40). The authors used routine insurance data of the Barmer GEK statutory health insurance company to analyze antipsychotic prescriptions for this age group from 2005 to 2012.
The Alliance for Home Health Quality and Innovation (the Alliance) today released research detailing the care pathways patients receive for three distinct episode types: post-acute, pre-acute and non-post-acute.
Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a $735,000 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research.
› Verified 2 days ago
| Entity Name | Central Peninsula General Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528062429 PECOS PAC ID: 4587552575 Enrollment ID: O20040310000598 |
News Archive
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Increasing numbers of children and adolescents are being given antipsychotic drugs in Germany, as Christian Bachmann and colleagues found out in a study published in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2014; 111(3): 25 - 40). The authors used routine insurance data of the Barmer GEK statutory health insurance company to analyze antipsychotic prescriptions for this age group from 2005 to 2012.
The Alliance for Home Health Quality and Innovation (the Alliance) today released research detailing the care pathways patients receive for three distinct episode types: post-acute, pre-acute and non-post-acute.
Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a $735,000 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research.
› Verified 2 days ago
| Entity Name | Kenai Spine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497002968 PECOS PAC ID: 2567617707 Enrollment ID: O20130219000472 |
News Archive
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Increasing numbers of children and adolescents are being given antipsychotic drugs in Germany, as Christian Bachmann and colleagues found out in a study published in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2014; 111(3): 25 - 40). The authors used routine insurance data of the Barmer GEK statutory health insurance company to analyze antipsychotic prescriptions for this age group from 2005 to 2012.
The Alliance for Home Health Quality and Innovation (the Alliance) today released research detailing the care pathways patients receive for three distinct episode types: post-acute, pre-acute and non-post-acute.
Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a $735,000 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John L Andreshak, MD 250 Hospital Pl, Soldotna, AK 99669-7559 Ph: (907) 714-5770 | John L Andreshak, MD 240 Hospital Pl Ste 104, Soldotna, AK 99669-7559 Ph: (907) 714-5770 |
News Archive
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Increasing numbers of children and adolescents are being given antipsychotic drugs in Germany, as Christian Bachmann and colleagues found out in a study published in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2014; 111(3): 25 - 40). The authors used routine insurance data of the Barmer GEK statutory health insurance company to analyze antipsychotic prescriptions for this age group from 2005 to 2012.
The Alliance for Home Health Quality and Innovation (the Alliance) today released research detailing the care pathways patients receive for three distinct episode types: post-acute, pre-acute and non-post-acute.
Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a $735,000 grant from the National Institute on Disability, Independent Living, and Rehabilitation Research.
› Verified 2 days ago
Samuel S. Adams, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 240 Hospital Pl Ste 104, Soldotna, AK 99669 Phone: 907-714-5770 Fax: 888-385-3430 | |
Michael L Reyes, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 240 Hospital Pl Ste 204b, Soldotna, AK 99669 Phone: 907-561-3211 | |
Dr. Eric Mark Hammerberg, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 240 Hospital Pl Ste 204b, Soldotna, AK 99669 Phone: 907-714-4120 Fax: 844-412-3943 | |
Henry G Krull, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 289 N Fireweed St Ste D, Soldotna, AK 99669 Phone: 907-262-6454 Fax: 907-262-0832 | |
David Scott Innes, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 250 Hospital Pl, Soldotna, AK 99669 Phone: 907-714-4130 Fax: 907-262-7735 | |
Herbert O Bote, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 240 Hospital Pl Ste 204, Soldotna, AK 99669 Phone: 907-714-4120 Fax: 844-412-3943 |